Novo Nordisk pays $26.7 million to settle claims

First Page		Document Content
Date: 2015-02-08 10:53:18 Peptide hormones Recombinant proteins Biotechnology Pharmaceutical sciences Insulin aspart Food and Drug Administration False Claims Act Biology Diabetes Novo Nordisk		Novo Nordisk pays $26.7 million to settle claims Add to Reading List Source URL: phys.org Download Document from Source Website File Size: 27,11 KB Share Document on Facebook